Half of people in the US would sell their genetic data for $95

The participants, a representative sample of the US population, watched a 3-minute video detailing both the commercial value of genomic data and genetic privacy issues. This included a statement that consumer genetic testing firm 23andMe sells access to its database to pharmaceutical firms for $140 per individual’s data.

While 38 per cent said they wouldn’t share their data, 50 per cent said they would if they were paid, and 12 per cent said they would do it for free.